1. Home
  2. WGSWW

as of 03-26-2026 9:53am EST

$0.01
+$0.00
+27.42%
Stocks Technology Retail: Computer Software & Peripheral Equipment Nasdaq

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Founded: 2017 Country:
United States
United States
Employees: 1300 City: STAMFORD
Market Cap: N/A IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 107.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.94 EPS Growth: N/A
52 Week Low/High: $0.00 - $0.23 Next Earning Date: 02-18-2025
Revenue: $305,450,000 Revenue Growth: 50.79%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -0.00 Index: N/A
Free Cash Flow: -33987000.0 FCF Growth: N/A

Latest GeneDx Holdings Corp. News

WGSWW Breaking Stock News: Dive into WGSWW Ticker-Specific Updates for Smart Investing

All WGSWW News

Share on Social Networks: